A biomarker of doping indicates the biological response to the use of a prohibited substance or method. Uncovering novel biomarkers of doping is a key objective in order to improve antidoping outcomes such as the detection of doping and changing athlete behavior toward doping practices. While the antidoping field has been successful in validating novel metabolites of prohibited substances, there has been less success in developing new biomarkers of doping. Employing the most suitable study designs and analytical approaches is critical to successfully uncovering novel biomarkers of doping with a high potential for translation into routine analysis. Here we argue that the antidoping field is well positioned for biomarker discovery and outline considerations for the development of novel biomarkers of doping.
CITATION STYLE
Aikin, R., Baume, N., Equey, T., & Rabin, O. (2020, June 1). Biomarkers of doping: Uses, discovery and validation. Bioanalysis. Future Medicine Ltd. https://doi.org/10.4155/bio-2020-0035
Mendeley helps you to discover research relevant for your work.